| Literature DB >> 30630091 |
Hao Jia1, Haolong Qi2, Zhongqin Gong3, Shucai Yang4, Jianwei Ren5, Yi Liu6, Ming-Yue Li7, George Gong Chen8.
Abstract
FOXP3 is a transcription factor, which belongs to the family of FOX protein. FOXP3 was initially discovered in regulatory T cells and supposed to play a significant role in the process of regulatory T cell differentiation. Increasing evidence has shown that FOXP3 is also expressed in tumor cells. However, the results of tumor FOXP3 is inconsistent and even the opposite. In some types of human cancers, the expression of FOXP3 is upregulated, and it can promote the development of cancers, leading to a poor prognosis. While in some other types of cancers, it is a different story. The reason for the contradictory data is unknown. The discovery of FOXP3 isoforms, interaction between tumor cells and lymphocytes in the tumor microenvironment, subcellular location, and mutation of FOXP3 may provide some clues. In this review, we first summarize and analyze the recent development. The final section focuses on the regulation of FOXP3 expression.Entities:
Keywords: Cancer; Expression; FOXP3; Growth; Isoforms; Prognosis
Mesh:
Substances:
Year: 2019 PMID: 30630091 DOI: 10.1016/j.bbcan.2018.12.004
Source DB: PubMed Journal: Biochim Biophys Acta Rev Cancer ISSN: 0304-419X Impact factor: 10.680